Recent Quarter Total Invested
$469,203
Recent Quarter Institutional Ownership Percentage
0.3%
Total Invested of Last Quarter
$731,097
Ownership Percentage of Last Quarter
0.32%
Innate Pharma S.A. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| OPTIVER HOLDING B.V. | 08/14/2024 | 87,352 | $169,463 | 23.79% | 0.11% |
| EXCHANGE TRADED CONCEPTS, LLC | 08/13/2024 | 86,237 | $167,300 | -23.73% | 0.11% |
| MORGAN STANLEY | 08/14/2024 | 43,524 | $84,437 | -1.36% | 0.05% |
| CITADEL ADVISORS LLC | 08/14/2024 | 23,527 | $45,642 | 100.00% | 0.03% |
| BARCLAYS PLC | 08/14/2024 | 412 | $1,000 | 0.00% | 0.00% |
| UBS GROUP AG | 08/14/2024 | 297 | $576 | 41.43% | 0.00% |
| RHUMBLINE ADVISERS | 08/01/2024 | 205 | $397 | 0.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/08/2024 | 200 | $388 | 0.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
Innate Pharma S.A.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of IPHA shares?
During the previous two years, 11 institutional investors and hedge funds held shares of Innate Pharma S.A.. The most heavily invested institutionals were:
Optiver Holding B.V.: 87,352
EXCHANGE TRADED CONCEPTS, LLC: 86,237
MORGAN STANLEY: 43,524
CITADEL ADVISORS LLC: 23,527
BARCLAYS PLC: 412
UBS Group AG: 297
-
What percentage of Innate Pharma S.A. stock is owned by institutional investors?
0.30% of Innate Pharma S.A. stock is owned by institutional investors.
-
How much institutional buying is happening at IPHA ?
Institutional investors have bought a total of 241,769 shares in the last 24 months. This purchase volume represents approximately $524,639 in transactions.